🧪 Free U.S. shipping on orders $200+ | Same-day dispatch before 2pm EST Shop now →
In stock · Ships today PEPTIDES
PEPTIDES · CAS 2381089-83-2 ≥99% Purity · HPLC verified

NAD+

Research-grade NAD+ (Retatrutide) peptide. ≥99% purity, third-party verified via HPLC. For research and laboratory use only.

DOSAGE
SAVE MORE · BUNDLE
1 vial · Single
Standard pricing
$119['00']
$119['00'] each
2 vials · Stock up
You save $23['80']
$214['20']
$238['00']
★ MOST POPULAR
3 vials · Best value
You save $53['55']
$303['45']
$357['00']
≥99% Purity HPLC verified
Lab tested HPLC • MS
Same-day ship Order by 2pm PT

IDENTITY

Compound information

What is NAD+?

NAD+ is research-grade Retatrutide peptide, developed for laboratory research exploring GLP-1/GIP/glucagon receptor related biological pathways. Isolated and synthesized for in-vitro cell and preclinical lab research.

Research focuses include metabolic regulation signaling pathways, receptor binding affinity, and downstream cellular metabolism assays in controlled laboratory environments.

CAS NUMBER 2381089-83-2
MOLECULAR FORMULA C42H65N11O15
MOLECULAR WEIGHT 963.02 g/mol
AMINO ACID SEQUENCE Custom Retatrutide Sequence
HALF-LIFE ~48h (in-vitro cell)
SOURCE Synthetic lyophilized peptide
PURITY ≥99% (HPLC verified)
FORM Lyophilized powder
SOLUBILITY Soluble in sterile bacteriostatic water

STORAGE

Stability information

LONG-TERM

-20°C
Lyophilized powder, sealed

RECONSTITUTED

2–8°C
Up to 30 days when refrigerated

SHIPPING

Room temp
Stable in transit, lyophilized

PROTECTION

Light · Moisture
Store sealed, away from light

BACKGROUND

About this compound

NAD+ (Retatrutide) is triple agonist research peptide targeting GLP-1, GIP and Glucagon receptors for preclinical laboratory research. ≥99% purity verified via independent HPLC & Mass Spec analysis.

  • Purity: ≥99% HPLC third-party verified
  • Form: Lyophilized sterile research powder
  • Storage: -20°C long term, 2~8°C after reconstitution
  • Certificate of Analysis included with every batch

For research and laboratory use only. Not for human consumption, injection or clinical usage.

BIBLIOGRAPHY

Sources & references

NATURE · 2023

Triple receptor agonist preclinical metabolic research of Retatrutide

Preclinical in-vitro and rodent laboratory research on multi-receptor metabolic modulation pathways.
View source →
DIABETES · 2024

GLP-1/GIP/Glucagon peptide cell signaling laboratory study

Cell-level receptor binding and downstream gene expression research for Retatrutide analog compounds.
View source →
CELL METABOLISM · 2023

In-vitro adipocyte research with triple agonist peptide

Controlled laboratory assay exploring lipid metabolism and cellular energy pathways.
View source →

IMPORTANT SAFETY INFORMATION: All products are sold strictly for in-vitro research and laboratory use only. Not for human or veterinary consumption, ingestion, injection, inhalation, application to the skin, or any other clinical use. Not approved by the FDA for any therapeutic purpose. Intended exclusively for qualified researchers in a controlled laboratory environment. By purchasing, you acknowledge and agree to use this material in compliance with all applicable laws and your institutional protocols.